Use of disease-modifying drugs (tocilizumab, tofacitinib, and baricitinib—a biological or synthetic target specific) in patients hospitalized with COVID-19

Overview of attention for article published in Revista da Associação Médica Brasileira, January 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (84th percentile)

So far, Dimensions has found 1 citation of this research output.

The most recent citing publication is shown below. View this citation on Dimensions.

Article in International Immunopharmacology (June 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.